76 patents currently held
46 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2032. from the record
Of the 46 now held by other companies, 25 name Biotyx Medical Shenzhen Co. Ltd. as their current owner, and 21 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2032
Next term end
71
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2033 · High confidence
Also notable
Ends Dec 2039 · High confidence
Also notable
Ends Oct 2041 · Medium confidence
Left Atrial Appendage Occluder
US 10,258,343
The most cited patent in this portfolio, cited by 26 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2033.
Delivery Device
US 11,596,536
Granted 2023. Computed term ends 2039.
Delivery Device, and Intravascular Stent System
US 12,797,214
Granted 2026. Too new for citation comparison; protection runs to 2041.
Formerly held, still cited
Notable
Ends Nov 2035 · High confidence
Granted 2022. Computed term ends 2035.
now held by Biotyx Medical (Shenzhen) Co., Ltd.
Also notable
Ends Jun 2036 · High confidence
Granted 2023. Computed term ends 2036.
now held by Biotyx Medical (Shenzhen) Co., Ltd.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Occluder and Occlusion Device (US 10,314,727) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 2 fees due May 7 to 14, 2027 · next May 7
- 2 fees due Jul 16 to 23, 2027 · next Jul 16
- 1 fee due Aug 4, 2027The maintenance fee for Aortic Arch Intraoperative Stent and Manufacturing Method Thereof (US 10,548,709) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
- 2 fees due Sep 5 to 17, 2027 · next Sep 5
- 5 fees due Oct 9 to 23, 2027 · next Oct 9
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
What they patent
The largest of its 71 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Left Atrial Appendage Occluder (2014) | 3 in force | to Apr 2034 |
| Puncturing Device and Anchoring Device | 2 in force | to Dec 2038 |
| Left Atrial Appendage Occluder (2017) | 2 in force | to Nov 2037 |
| Left Atrial Appendage Occluder (2016) | 2 in force | to Aug 2035 |
| Sheath | 1 in force | to Oct 2043 |
| Conveyor and Lumen Apparatus Conveying System | 1 in force | to Oct 2043 |
| Medical Apparatus System | 1 in force | to May 2043 |
| Occluder and Occluding System | 1 in force | to Oct 2042 |
| Embolic Protection Device | 1 in force | to Sep 2042 |
| Delivery Device and Delivery System | 1 in force | to Aug 2042 |
| Plugging Device | 1 in force | to Jul 2042 |
| Neostomy Apparatus | 1 in force | to May 2042 |
| Delivery Device, and Intravascular Stent System | 1 in force | to Oct 2041 |
| Covered Stent | 1 in force | to Jun 2041 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,877,726 | Occlusion Device and Method for its Manufacture In force · High confidence | In force | High confidence | |
| US 9,307,999 | Interventional Medical Device Connector and Method for Using Same In force · High confidence | In force | High confidence | |
| US 9,808,253 | Left Atrial Appendage Occluder In force · High confidence | In force | High confidence | |
| US 10,258,343 | Left Atrial Appendage Occluder In force · High confidence | In force | High confidence | |
| US 11,547,417 | Left Atrial Appendage Occluder In force · High confidence | In force | High confidence | |
| US 9,863,031 | Method for Preparing a Coating of the Surface of Medical Devices Made of Nickel-Titanium Alloy In force · High confidence | In force | High confidence | |
| US 9,789,232 | Medical Instrument Coating and Preparation Method Therefor and Medical Instrument Comprising Coating In force · High confidence | In force | High confidence | |
| US 10,251,763 | Braided Self-Expanding Endoluminal Stent and Manufacturing Method Thereof In force · High confidence | In force | High confidence | |
| US 10,010,402 | Thoracic Aortic Covered Stent In force · High confidence | In force | High confidence | |
| US 10,548,709 | Aortic Arch Intraoperative Stent and Manufacturing Method Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 76: 46 patents in force now held by others · 2 patents ended · 33 applications pending · 17 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.